Preliminary Final Report
Released
Released
Announcement PDF
Biome Australia Limited
Appendix 4E
Preliminary final report
1. Company details
Name of entity:
ABN:
Reporting period:
Previous period:
Biome Australia Limited
51 627 364 014
For the year ended 30 June 2025
For the year ended 30 June 2024
2. Results for announcement to the market
$
Revenues from ordinary activities
up
41.6% to
18,417,188
Profit from ordinary activities after tax attributable to the owners of Biome
Australia Limited
up
112.9% to
214,656
Profit for the year attributable to the owners of Biome Australia Limited
112.9% to
214,656
up
Dividends
There were no dividends paid, recommended or declared during the current financial period.
Comments
Biome reported its first profitable year since inception in 2018, with net profit achieved alongside strong operational metrics.
Revenue reached $18.4 million, up 41% year-on-year, significantly outperforming category growth rates by 7-10 times.
Key Financial Metrics
EBITDA* (excluding share based payments) was $931,050 for the full year, marking the sixth consecutive quarter of positive
EBITDA. Gross margin held steady at 61%. Q4 delivered $5 million in revenue with June posting a record monthly result of
$2.1 million.
Market Position
Activated Probiotics secured the number two position in total probiotic revenue within community pharmacy. Domestic sellthrough increased 50%+, establishing market leadership in category growth without relying on discount strategies.
International Expansion
International revenue hit $1.5 million, up 69% year-over-year. Distribution agreements secured across four markets: Canada
(Pure Pharmacy Group, Healthy Planet Group), Ireland (Uniphar serving 1,400+ pharmacies), UK (Planet Organic), and New
Zealand (Propharma - largest pharmacy network). These partnerships provide access to thousands of additional retail points.
Product Development
Launched Activated Therapeutics practitioner-only range with four products targeting specific therapeutic areas. Completed
proprietary strain development program, securing IP ownership of Lactobacillus plantarum BMB18, registered with German
culture bank DSMZ, creating potential future licensing revenue streams.
Outlook
Current performance trajectory supports Vision 27 target of $75 million cumulative sales for FY25-27. Strong cash position
and positive cash flow provide foundation for continued expansion without immediate capital requirements.
Financial Position
The Company has $2,746,416 in cash as at 30 June 2025 and a further $2,094,587 in an undrawn credit facility with NAB.
The net assets of the Company increased to $4,675,367 as at 30 June 2025 (30 June 2024: $2,903,528) which was a result
of increased capital from the exercise of company options and the Company reporting a net profit for the year.
Biome Australia Limited
Appendix 4E
Preliminary final report
3. Net tangible assets
Reporting
period
Cents
Net tangible assets per ordinary security
2.06
Previous
period
Cents
1.35
4. Control gained over entities
Not applicable.
5. Loss of control over entities
Not applicable.
6. Dividends
Current period
There were no dividends paid, recommended or declared during the current financial period.
Previous period
There were no dividends paid, recommended or declared during the previous financial period.
7. Dividend reinvestment plans
Not applicable.
8. Details of associates and joint venture entities
Not applicable.
9. Foreign entities
Details of origin of accounting standards used in compiling the report:
The consolidated entity has been consolidated in accordance with the Australian Accounting Standards and Interpretations
issued by the Australian Accounting Standards Board and the Corporations Act. They also comply with the International
Financial Reporting Standards as issued by the International Accounting Standards Board (‘IASB’).
10. Audit qualification or review
Details of audit/review dispute or qualification (if any):
This report is in the process of being audited. At the date of this report, the Directors are not aware of any matter that will
result in a qualification of the audit report
11. Attachments
Details of attachments (if any):
The Preliminary Financial Report of Biome Australia Limited for the year ended 30 June 2025 is attached.
Biome Australia Limited
ABN 51 627 364 014
Preliminary Financial Report - 30 June 2025
Biome Australia Limited
Statement of profit or loss and other comprehensive income
For the year ended 30 June 2025
Consolidated
Note 30 June 2025 30 June 2024
$
$
Revenue
Sales revenue
Cost of goods sold
5
18,417,188
(7,160,900)
13,008,897
(5,097,676)
11,256,288
7,911,221
6
482,396
415,749
7
7
(7,537,917)
(3,322,177)
(117,738)
(241,970)
(36,847)
(267,379)
(5,851,611)
(3,658,447)
(72,846)
(241,560)
(21,160)
(151,548)
214,656
(1,670,202)
Gross profit
Other income
Expenses
Sales and marketing expenses
Corporate and administrative expenses
Distribution and occupancy expenses
Depreciation, amortisation and impairments
Other expenses
Finance costs
7
7
Profit/(loss) before income tax expense
Income tax expense
8
-
-
Profit/(loss) after income tax expense for the year attributable to the owners of
Biome Australia Limited
25
214,656
(1,670,202)
Other comprehensive income for the year, net of tax
8
-
-
214,656
(1,670,202)
Cents
Cents
Total comprehensive income for the year attributable to the owners of Biome
Australia Limited
Basic earnings per share
Diluted earnings per share
34
34
0.10
0.10
The above statement of profit or loss and other comprehensive income should be read in conjunction with the
accompanying notes
1
(0.80)
(0.80)
Biome Australia Limited
Statement of financial position
As at 30 June 2025
Consolidated
Note 30 June 2025 30 June 2024
$
$
Assets
Current assets
Cash and cash equivalents
Trade and other receivables
Inventories
Other
Total current assets
9
10
11
12
2,746,416
4,327,593
4,111,914
255,306
11,441,229
2,868,526
2,870,022
1,888,577
81,361
7,708,486
Non-current assets
Property, plant and equipment
Right-of-use assets
Intangibles
Total non-current assets
13
14
15
224,585
138,887
163,239
526,711
331,380
236,925
568,305
11,967,940
8,276,791
Total assets
Liabilities
Current liabilities
Trade and other payables
Borrowings
Lease liabilities
Employee benefits
Total current liabilities
16
17
18
19
3,600,102
2,905,413
116,833
557,676
7,180,024
2,492,301
1,020,597
107,952
1,522,673
5,143,523
Non-current liabilities
Lease liabilities
Employee benefits
Other liabilities
Total non-current liabilities
20
21
22
50,979
61,570
112,549
167,812
52,570
9,358
229,740
Total liabilities
7,292,573
5,373,263
Net assets
4,675,367
2,903,528
23,323,346
406,618
(19,054,597)
21,727,165
444,212
(19,267,849)
4,675,367
2,903,528
Equity
Issued capital
Reserves
Accumulated losses
23
24
25
Total equity
The above statement of financial position should be read in conjunction with the accompanying notes
2
Biome Australia Limited
Statement of changes in equity
For the year ended 30 June 2025
Consolidated
Issued
capital
$
Balance at 1 July 2023
20,764,055
421,257
(17,599,047)
3,586,265
Loss after income tax expense for the year
Other comprehensive income for the year, net
of tax
-
-
(1,670,202)
(1,670,202)
-
-
-
-
Total comprehensive income for the year
-
-
(1,670,202)
(1,670,202)
122,532
840,578
-
92,987
128,125
(198,157)
-
1,400
215,519
128,125
642,421
1,400
Balance at 30 June 2024
21,727,165
444,212
(19,267,849)
2,903,528
Consolidated
Issued
capital
$
Balance at 1 July 2024
21,727,165
444,212
(19,267,849)
2,903,528
Profit after income tax expense for the year
Other comprehensive income for the year, net
of tax
-
-
214,656
214,656
-
-
-
-
Total comprehensive income for the year
-
-
214,656
214,656
Transactions with owners in their capacity as
owners:
Share-based payments (note 35)
Issue of options
Exercise of options
Consolidation - currency adjustment
471,619
1,124,562
-
(37,594)
-
(1,404)
434,025
1,124,562
(1,404)
Balance at 30 June 2025
23,323,346
406,618
(19,054,597)
4,675,367
Transactions with owners in their capacity as
owners:
Share-based payments (note 35)
Issue of options
Exercise of options
Consolidation - currency adjustment
Option
Reserves
$
Accumulated
losses
Total equity
$
$
Option
Reserves
$
Accumulated
losses
Total equity
$
$
The above statement of changes in equity should be read in conjunction with the accompanying notes
3
Biome Australia Limited
Statement of cash flows
For the year ended 30 June 2025
Consolidated
Note 30 June 2025 30 June 2024
$
$
Cash flows from operating activities
Receipts from customers (inclusive of GST)
Payments to suppliers (inclusive of GST)
R&D tax refund
Export Market Development Grant and State Government grants
Interest paid on lease liabilities
Interest received
16,833,117
(19,994,220)
337,167
73,084
(139,952)
71,145
12,790,769
(13,354,625)
314,937
36,600
(15,699)
64,212
Net cash used in operating activities
33
(2,819,659)
(163,806)
Cash flows from investing activities
Payments for property, plant and equipment
Payments for intellectual property
13
(37,138)
(163,239)
(21,607)
-
(200,377)
(21,607)
1,124,562
27,500
(108,952)
2,904,816
(1,050,000)
642,421
(99,585)
520,597
(270,258)
Net cash from financing activities
2,897,96
793,175
Net increase/(decrease) in cash and cash equivalents
Cash and cash equivalents at the beginning of the financial year
(122,110)
2,868,526
607,762
2,260,764
2,746,416
2,868,526
Net cash used in investing activities
Cash flows from financing activities
Proceeds from exercise of options
Proceeds from repayment of Employee Funded Loan Share Plan
Repayments for lease liabilities
Proceeds from borrowings
Repayment of borrowings
Cash and cash equivalents at the end of the financial year
23
9
The above statement of cash flows should be read in conjunction with the accompanying notes
4
Biome Australia Limited
Notes to the financial statements
30 June 2025
Note 1. General information
The financial statements cover Biome Australia Limited as a consolidated entity consisting of Biome Australia Limited and the
entities it controlled at the end of, or during, the year. The financial statements are presented in Australian dollars, which is
Biome Australia Limited's functional and presentation currency.
Biome Australia Limited is a listed public company limited by shares, incorporated and domiciled in Australia. Its registered
office and principal place of business are:
Registered office
Principal place of business
192-194 Johnston Street
Collingwood Victoria 3066
192-194 Johnston Street
Collingwood Victoria 3066
A description of the nature of the consolidated entity's operations and its principal activities are included in the directors' report,
which is not part of the financial statements.
The financial statements were authorised for issue, in accordance with a resolution of directors, on 27 August 2025. The
directors have the power to amend and reissue the financial statements.
Note 2. Material accounting policy information
The accounting policies that are material to the consolidated entity are set out either in the respective notes or below. The
accounting policies adopted are consistent with those of the previous financial year, unless otherwise stated.
New or amended Accounting Standards and Interpretations adopted
The consolidated entity has adopted all of the new or amended Accounting Standards and Interpretations issued by the
Australian Accounting Standards Board ('AASB') that are mandatory for the current reporting period.
Any new or amended Accounting Standards or Interpretations that are not yet mandatory have not been early adopted.
Basis of preparation
These general purpose financial statements have been prepared in accordance with Australian Accounting Standards and
Interpretations issued by the Australian Accounting Standards Board ('AASB') and the Corporations Act 2001, as appropriate
for for-profit oriented entities. These financial statements also comply with International Financial Reporting Standards as
issued by the International Accounting Standards Board ('IASB').
Historical cost convention
The financial statements have been prepared under the historical cost convention, except for, where applicable, the
revaluation of financial assets and liabilities at fair value through profit or loss, financial assets at fair value through other
comprehensive income, investment properties, certain classes of property, plant and equipment and derivative financial
instruments.
Critical accounting estimates
The preparation of the financial statements requires the use of certain critical accounting estimates. It also requires
management to exercise its judgement in the process of applying the consolidated entity's accounting policies. The areas
involving a higher degree of judgement or complexity, or areas where assumptions and estimates are significant to the financial
statements, are disclosed in note 3.
Parent entity information
In accordance with the Corporations Act 2001, these financial statements present the results of the consolidated entity only.
Supplementary information about the parent entity is disclosed in note 31.
5
Biome Australia Limited
Notes to the financial statements
30 June 2025
Note 2. Material accounting policy information (continued)
Revenue recognition
The consolidated entity recognises revenue as follows:
Revenue from contracts with customers
Revenue is recognised at an amount that reflects the consideration to which the consolidated entity is expected to be entitled
in exchange for transferring goods or services to a customer. For each contract with a customer, the consolidated entity:
identifies the contract with a customer; identifies the performance obligations in the contract; determines the transaction price
which takes into account estimates of variable consideration and the time value of money; allocates the transaction price to
the separate performance obligations on the basis of the relative stand-alone selling price of each distinct good or service to
be delivered; and recognises revenue when or as each performance obligation is satisfied in a manner that depicts the transfer
to the customer of the goods or services promised.
Variable consideration within the transaction price, if any, reflects concessions provided to the customer such as discounts,
rebates and refunds, any potential bonuses receivable from the customer and any other contingent events. Such estimates
are determined using either the 'expected value' or 'most likely amount' method. The measurement of variable consideration
is subject to a constraining principle whereby revenue will only be recognised to the extent that it is highly probable that a
significant reversal in the amount of cumulative revenue recognised will not occur. The measurement constraint continues
until the uncertainty associated with the variable consideration is subsequently resolved. Amounts received that are subject
to the constraining principle are recognised as a refund liability.
Sale of goods
Revenue from the sale of goods is recognised at the point in time when the customer obtains control of the goods, which is
generally at the time of delivery.
Rendering of services
Revenue from a contract to provide services is recognised over time as the services are rendered based on either a fixed
price or an hourly rate.
Interest
Interest revenue is recognised as interest accrues using the effective interest method. This is a method of calculating the
amortised cost of a financial asset and allocating the interest income over the relevant period using the effective interest rate,
which is the rate that exactly discounts estimated future cash receipts through the expected life of the financial asset to the
net carrying amount of the financial asset.
Other revenue
Other revenue is recognised when it is received or when the right to receive payment is established.
Impairment of non-financial assets
Non-financial assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying
amount may not be recoverable. An impairment loss is recognised for the amount by which the asset's carrying amount
exceeds its recoverable amount.
Recoverable amount is the higher of an asset's fair value less costs of disposal and value-in-use. The value-in-use is the
present value of the estimated future cash flows relating to the asset using a pre-tax discount rate specific to the asset or
cash-generating unit to which the asset belongs. Assets that do not have independent cash flows are grouped together to
form a cash-generating unit.
New Accounting Standards and Interpretations not yet mandatory or early adopted
Australian Accounting Standards and Interpretations that have recently been issued or amended but are not yet mandatory,
have not been early adopted by the consolidated entity for the annual reporting period ended 30 June 2025. The consolidated
entity has not yet assessed the impact of these new or amended Accounting Standards and Interpretations.
6
Biome Australia Limited
Notes to the financial statements
30 June 2025
Note 3. Critical accounting judgements, estimates and assumptions
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect
the reported amounts in the financial statements. Management continually evaluates its judgements and estimates in relation
to assets, liabilities, contingent liabilities, revenue and expenses. Management bases its judgements, estimates and
assumptions on historical experience and on other various factors, including expectations of future events, management
believes to be reasonable under the circumstances. The resulting accounting judgements and estimates will seldom equal the
related actual results. The judgements, estimates and assumptions that have a significant risk of causing a material adjustment
to the carrying amounts of assets and liabilities (refer to the respective notes) within the next financial year are discussed
below.
Share-based payment transactions
The consolidated entity measures the cost of equity-settled transactions with employees by reference to the fair value of the
equity instruments at the date at which they are granted. The fair value is determined by using either the Binomial or BlackScholes model taking into account the terms and conditions upon which the instruments were granted. The accounting
estimates and assumptions relating to equity-settled share-based payments would have no impact on the carrying amounts
of assets and liabilities within the next annual reporting period but may impact profit or loss and equity.
Provision for impairment of inventories
The provision for impairment of inventories assessment requires a degree of estimation and judgement. The level of the
provision is assessed by taking into account the recent sales experience, the ageing of inventories and other factors that affect
inventory obsolescence.
Estimation of useful lives of assets
The consolidated entity determines the estimated useful lives and related depreciation and amortisation charges for its
property, plant and equipment and finite life intangible assets. The useful lives could change significantly as a result of technical
innovations or some other event. The depreciation and amortisation charge will increase where the useful lives are less than
previously estimated lives, or technically obsolete or non-strategic assets that have been abandoned or sold will be written off
or written down.
Recovery of deferred tax assets
Deferred tax assets are recognised for deductible temporary differences only if the consolidated entity considers it is probable
that future taxable amounts will be available to utilise those temporary differences and losses.
Note 4. Operating segments
Identification of reportable operating segments
The company is organised into one operating segment: researching, developing, manufacturing and distributing innovative
evidence-based products linking the gut and human health. This operating segment is based on the internal reports that are
reviewed and used by the Board of Directors (who are identified as the Chief Operating Decision Makers ('CODM')) in
assessing performance and in determining the allocation of resources. There is no aggregation of operating segments.
Accounting policy for operating segments
Operating segments are presented using the 'management approach', where the information presented is on the same basis
as the internal reports provided to the Chief Operating Decision Makers ('CODM'). The CODM is responsible for the allocation
of resources to operating segments and assessing their performance.
Note 5. Sales revenue
Consolidated
30 June 2025 30 June 2024
$
$
Sales - Domestic
Sales - International
7
16,930,499
1,486,689
12,114,477
894,420
18,417,188
13,008,897
Biome Australia Limited
Notes to the financial statements
30 June 2025
Note 6. Other income
Consolidated
30 June 2025 30 June 2024
$
$
Other income (incl. EMDG - Export Market Development Grant)
Interest income
R&D tax refund
73,084
72,145
337,167
36,600
64,212
314,937
Other income
482,396
415,749
Note 7. Expenses
Consolidated
30 June 2025 30 June 2024
$
$
Selling and marketing expenses
Employee costs
Overseas contractors / consultants
Sales, marketing and research expenses
Warehousing, distribution and fulfilment
Travel and entertainment expenses
Share based payments
3,099,949
699,241
1,385,869
1,486,524
769,873
96,461
2,449,669
397,436
1,264,654
1,039,570
580,848
119,434
7,537,917
5,851,611
Consolidated
30 June 2025 30 June 2024
Corporate and administrative expenses
Employee costs
CEO - Long term incentive
Consulting fees
Accounting fees
IT expenses
Insurance
Secretarial fees
Legal fees
Other administrative expenses
Share based payments (*)
2,114,455
92,295
82,204
213,836
158,301
92,168
146,028
112,825
310,065
1,653,574
1,000,000
65,427
125,048
156,307
109,271
78,264
119,039
127,748
223,769
3,322,177
3,658,447
(*) includes $110,000 (FY24 $128,128) for share based payments to non-related third party service providers
Consolidated
30 June 2025 30 June 2024
$
$
Depreciation, amortisation and impairments
Depreciation expense
Amortisation expense on right-of-use asset
8
143,932
98,038
143,522
98,038
241,970
241,560
Biome Australia Limited
Notes to the financial statements
30 June 2025
Note 7. Expenses (continued)
Consolidated
30 June 2025 30 June 2024
Finance costs
Interest expense
Interest expense on leases/right-of-use assets
Bank charges
Merchant fees
Foreign exchange losses/(gains)
129,253
10,789
52,494
4,136
70,707
144,787
15,699
1,455
3,383
(13,776)
267,379
151,548
Note 8. Income tax expense
Consolidated
30 June
30 June 2025
2024
$
$
Numerical reconciliation of income tax expense and tax at the statutory rate
Profit/(loss) before income tax expense
214,656
(1,670,202)
Tax at the statutory tax rate of 25%
53,664
(417,551)
Tax effect amounts which are not deductible/(taxable) in calculating taxable income:
Effects of different tax rates for foreign subsidiary
R&D refund
R&D expenses
Share-based payments
Timing differences not recognised
56,507
(84,292)
193,774
101,632
(55,290)
28,891
(78,743)
180,998
32,031
841,041
Prior year tax losses utilised
Current year tax losses not recognised
265.995
(265.995)
-
586,667
(586,667)
-
-
Income tax expense
Consolidated
30 June 2025 30 June 2024
$
$
Tax losses not recognised
Unused tax losses for which no deferred tax asset has been recognised
10,501,653
10,767,648
Potential tax benefit @ 25%
2,625,413
2,691,912
The above potential tax benefit for tax losses has not been recognised in the statement of financial position. These tax losses
can only be utilised in the future if the continuity of ownership test is passed, or failing that, the same business test is passed
and the Group generates sufficient taxable earnings.
9
Biome Australia Limited
Notes to the financial statements
30 June 2025
Note 9. Current assets - cash and cash equivalents
Consolidated
30 June 2025 30 June 2024
$
$
Cash at bank
2,746,416
2,868,526
Accounting policy for cash and cash equivalents
Cash and cash equivalents includes cash on hand, deposits held at call with financial institutions, other short-term, highly
liquid investments with original maturities of three months or less that are readily convertible to known amounts of cash and
which are subject to an insignificant risk of changes in value.
Note 10. Current assets - trade and other receivables
Consolidated
30 June 2025 30 June 2024
$
$
Trade receivables
4,327,593
2,870,022
Accounting policy for trade and other receivables
Trade receivables are initially recognised at fair value and subsequently measured at amortised cost using the effective
interest method, less any allowance for expected credit losses. Trade receivables are generally due for settlement within 30
days.
The consolidated entity has applied the simplified approach to measuring expected credit losses, which uses a lifetime
expected loss allowance. To measure the expected credit losses, trade receivables have been grouped based on days
overdue.
Note 11. Current assets - inventories
Consolidated
30 June 2025 30 June 2024
$
$
Raw materials - at cost
Finished goods - at cost
Provision for slow moving and obsolete stock
490,958
3,666,706
(45,750)
382,388
1,812,308
(306,119)
4,111,914
1,888,577
Accounting policy for inventories
Raw materials, work in progress and finished goods are stated at the lower of cost and net realisable value on a 'first in first
out' basis. Cost comprises of direct materials and delivery costs, direct labour, import duties and other taxes, an appropriate
proportion of variable and fixed overhead expenditure based on normal operating capacity, and, where applicable, transfers
from cash flow hedging reserves in equity. Costs of purchased inventory are determined after deducting rebates and discounts
received or receivable.
Stock in transit is stated at the lower of cost and net realisable value. Cost comprises of purchase and delivery costs, net of
rebates and discounts received or receivable.
Net realisable value is the estimated selling price in the ordinary course of business less the estimated costs of completion
and the estimated costs necessary to make the sale.
10
Biome Australia Limited
Notes to the financial statements
30 June 2025
Note 12. Current assets - other
Consolidated
30 June 2025 30 June 2024
$
$
Bank guarantee
Prepayments
Other
30,250
168,319
56,737
30,250
51,111
255,306
81,361
Note 13. Non-current assets - property, plant and equipment
Consolidated
30 June 2025 30 June 2024
$
$
Property, plant and equipment - at cost
Less: Accumulated depreciation
590,618
(366,033)
637,019
(305,639)
224,585
331,380
Reconciliations
Reconciliations of the written down values at the beginning and end of the current and previous financial year are set out
below:
Office
Equipment
and Furniture,
Fixtures and
Fittings
Motor
Vehicles
Leasehold
Improvement
Consolidated
$
$
$
Balance at 1 July 2023
Additions
Depreciation expense
52,273
21,607
(11,930)
20,104
(20,104)
380,918
(111,488)
453,295
21,607
(143,522)
Balance at 30 June 2024
Additions
Disposals
Depreciation expense
61,950
37,138
(18,720)
-
269,430
(125,213)
331,380
37,138
(143,933)
Balance at 30 June 2025
80,368
-
144,217
224,585
Total
$
Accounting policy for property, plant and equipment
Plant and equipment is stated at historical cost less accumulated depreciation and impairment. Historical cost includes
expenditure that is directly attributable to the acquisition of the items.
Depreciation is calculated on a straight-line basis to write off the net cost of each item of property, plant and equipment
(excluding land) over their expected useful lives as follows:
Leasehold improvements
Motor vehicles
Plant and equipment
3-10 years
4 years
3-7 years
The residual values, useful lives and depreciation methods are reviewed, and adjusted if appropriate, at each reporting date.
11
Biome Australia Limited
Notes to the financial statements
30 June 2025
Note 13. Non-current assets - property, plant and equipment (continued)
Leasehold improvements are depreciated over the unexpired period of the lease or the estimated useful life of the assets,
whichever is shorter.
An item of property, plant and equipment is derecognised upon disposal or when there is no future economic benefit to the
consolidated entity. Gains and losses between the carrying amount and the disposal proceeds are taken to profit or loss.
Note 14. Non-current assets - right-of-use assets
Consolidated
30 June 2025 30 June 2024
$
$
Right-of-use assets
Amortisation expense
490,189
(351,302)
490,189
(253,264)
138,887
236,925
Accounting policy for right-of-use assets
A right-of-use asset is recognised at the commencement date of a lease. The right-of-use asset is measured at cost, which
comprises the initial amount of the lease liability, adjusted for, as applicable, any lease payments made at or before the
commencement date net of any lease incentives received, any initial direct costs incurred, and, except where included in the
cost of inventories, an estimate of costs expected to be incurred for dismantling and removing the underlying asset, and
restoring the site or asset.
Right-of-use assets are depreciated on a straight-line basis over the unexpired period of the lease or the estimated useful life
of the asset, whichever is the shorter. Where the consolidated entity expects to obtain ownership of the leased asset at the
end of the lease term, the depreciation is over its estimated useful life. Right-of use assets are subject to impairment or
adjusted for any remeasurement of lease liabilities.
Note 15. Non-current assets - intangibles
Consolidated
30 June 2025 30 June 2024
$
$
Intellect
Share your feedback
Discover